Growth Metrics

Exagen (XGN) Return on Assets (2019 - 2025)

Historic Return on Assets for Exagen (XGN) over the last 7 years, with Q3 2025 value amounting to 0.31%.

  • Exagen's Return on Assets rose 500.0% to 0.31% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.31%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.3% for FY2024, which is 300.0% up from last year.
  • Exagen's Return on Assets amounted to 0.31% in Q3 2025, which was up 500.0% from 0.34% recorded in Q2 2025.
  • In the past 5 years, Exagen's Return on Assets registered a high of 0.15% during Q2 2021, and its lowest value of 0.55% during Q1 2023.
  • Moreover, its 5-year median value for Return on Assets was 0.35% (2024), whereas its average is 0.35%.
  • Per our database at Business Quant, Exagen's Return on Assets tumbled by -3000bps in 2022 and then surged by 2000bps in 2024.
  • Over the past 5 years, Exagen's Return on Assets (Quarter) stood at 0.21% in 2021, then crashed by -142bps to 0.52% in 2022, then grew by 22bps to 0.4% in 2023, then increased by 15bps to 0.34% in 2024, then rose by 9bps to 0.31% in 2025.
  • Its last three reported values are 0.31% in Q3 2025, 0.34% for Q2 2025, and 0.36% during Q1 2025.